ProCE Banner Activity

Expanding the Applicability Beyond HER2m and EGFRm: TROP-2–Targeted ADCs in NSCLC and ADCs in Patients with SCLC

Slideset

Downloadable slides from a live satellite symposium on the use of TROP-2–targeted ADCs for patients with NSCLC and new data on the future of ADCs in patients with SCLC.

Released: September 16, 2024

Expiration: September 15, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.